EquityFlow
›
Companies
› Evonetix
Evonetix
Biotech
· Cambridge, GB
Silicon-chip-based DNA synthesis technology
Funding history
Date
Round
Amount
Feb 2023
Series B
UK synthetic-biology company Evonetix raised a $24m Series B extension led by Foresite Capital (with Molten Ventures), bringing the round to $54m.
$24M
Investors
DCVC
Foresite Capital
Molten Ventures
Morningside
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →